Endpoint | PharmaBharat Tools

Loading term…

About Us Contact Us Disclaimer Privacy Policy Terms and Conditions

© 2026 PharmaBharat. All rights reserved.

Endpoint | PharmaBharat Tools

Categories

Advertising, Promotion & Medical Information(7)

Biologics, Biosimilars & ATMPs(9)

Clinical Trial Regulations(32)

Bioequivalence(BE)Blinding Clinical Study Report(CSR)Clinical Trial Clinical Trials Information System(CTIS)Data Monitoring Committee(DMC)Endpoint EU Clinical Trials Regulation(CTR)Expedited Safety Report Statement of Investigator(FDA 1572)ICH Good Clinical Practice(ICH GCP)Independent Ethics Committee(IEC)Informed Consent Interim Analysis Investigator's Brochure(IB)Institutional Review Board(IRB)Primary Endpoint Clinical Trial Protocol Protocol Amendment Protocol Deviation Randomization Reference Safety Information(RSI)Serious Adverse Event(SAE)Secondary Endpoint Serious Breach Statistical Analysis Plan(SAP)Substantial Amendment Substantial Modification Surrogate Endpoint Suspected Unexpected Serious Adverse Reaction(SUSAR)Trial Master File(TMF)Unblinding

Combination Products & Devices(5)

eCTD & Publishing(19)

EU Procedures & Committees(19)

Expedited & Special Programs(11)

FDA Meetings & Communication(7)

Global Guidance & Harmonisation(5)

ICH Guidelines (E/Q/M Series)(61)

Compliance & Inspections(11)

Post-Approval(25)

Regulatory Strategy & Planning(10)

Regulatory Submissions(25)

User Fees, Timelines & Review(17)

Variations & Amendments(8)

Progress

0%

RA Clinical Trial RegulationsEndpoint

Loading term…

Data Monitoring Committee (DMC)EU Clinical Trials Regulation (CTR)

Endpoint

Clinical Trial Regulations

Definition

A precisely defined outcome measure used to assess treatment effect in a clinical study.